Whether to increase sales by tracking the patterns in what we buy, or plotting power use to plan for a community’s energy needs, gathering and interpreting data in new ways is delivering valuable and sometimes unexpected benefits.
The explosion in the quantity and variety of data now collected, along with new technologies to visualise and creatively analyse it, is revealing secrets and surprising interconnections previously unknown. New insights are paving the way to research breakthroughs across the disciplines.
This lecture brings big data to life, featuring international leaders in data research who’ll share how their discoveries are protecting the health of astronauts in space, keeping us health and fitness aware and helping devise new treatments for cancer.
Dr Carolyn McGregor AM
UTS alumnus Carolyn McGregor is Canada Research Chair in Health Informatics at University of Ontario Institute of Technology. She has led pioneering research in event stream processing, temporal data stream data mining, business process modelling and service-oriented architectures. Her work focusses on the health of premature infants, tactical operators, astronauts and cosmonauts. Hear a snippet of Dr Mcgregor discussing her work.
Associate Professor Valerie Gay & Dr Peter Leijdekkers
Valerie Gay and Peter Leijdekkers are partners in life and in research discovery and invention; working together for the past 11 years in the UTS Faculty of Engineering and Information Technology. Their work harnesses data from mobile devices and wearable technology, such as Fitbits, to reveal an individual person’s health and wellbeing. Their research continues to grow in sophistication, enabling users of their applications to get personalised health and fitness feedback and keep track of health and fitness milestones.
Dr Dominik Beck
Dominik Beck is a NHMRC Peter Doherty Fellow & Senior Lecturer at the UTS Centre for Health Technologies and Lowy Cancer Research Centre at UNSW. With an interdisciplinary team of haematologists, wet-lab and computer scientists, he harnesses state-of-the-art bio and information technologies to identify molecular signatures allowing more personalised treatment of cancer patients. His work focuses on identifying risk factors and treatment options for patients suffering from a pair of related blood disorders – acute myeloid leukaemia and myelodysplasia.